Cargando…
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
BACKGROUND: Sarcopenia is a prognostic factor for patients with liver cirrhosis and hepatocellular carcinoma, and it affects the onset of hepatic encephalopathy. Therefore, the prevention of sarcopenia contributes to the improvement of the prognosis of patients with chronic liver disease (CLD). We f...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785279/ https://www.ncbi.nlm.nih.gov/pubmed/31636786 http://dx.doi.org/10.14740/jocmr3978 |
_version_ | 1783457864202846208 |
---|---|
author | Ohashi, Kazuki Ishikawa, Toru Hoshii, Asami Hokari, Tamaki Suzuki, Mitsuyuki Mitobe, Yuta Yamada, Etsuko Abeywickrama, Hansani Madushika Kikuchi, Yuko Noguchi, Hirohito Hirosawa, Hiroshi Koyama, Yu |
author_facet | Ohashi, Kazuki Ishikawa, Toru Hoshii, Asami Hokari, Tamaki Suzuki, Mitsuyuki Mitobe, Yuta Yamada, Etsuko Abeywickrama, Hansani Madushika Kikuchi, Yuko Noguchi, Hirohito Hirosawa, Hiroshi Koyama, Yu |
author_sort | Ohashi, Kazuki |
collection | PubMed |
description | BACKGROUND: Sarcopenia is a prognostic factor for patients with liver cirrhosis and hepatocellular carcinoma, and it affects the onset of hepatic encephalopathy. Therefore, the prevention of sarcopenia contributes to the improvement of the prognosis of patients with chronic liver disease (CLD). We focused on changes of hand grip strength (HGS), one of the indicators of sarcopenia. However, there are little data investigating the impact of physical activity (PA) on HGS in patients with CLD. This study aimed to clarify whether PA contributes to the prevention of muscle weakness in patients with CLD. METHODS: This was a prospective observational study. We examined the effect of PA on changes in HGS from the baseline to the endpoint in each group. Metabolic equivalents-hour/week (METs-h/w) was used to evaluate PA. In total, 183 outpatients with CLD were analyzed. We divided participants into four groups (low PA in younger patients (n = 20), high PA in younger patients (n = 33), low PA in elderly patients (n = 47), and high PA in elderly patients (n = 83)). RESULTS: Fifty-eight percent of patients were men, and the median (interquartile range) age was 69.0 (63.0, 75.0) years. The most common etiology of liver disease was hepatitis C (38%). The frequency of living alone and low exercise habit was significantly high, and sarcopenia was more obvious in elderly patients with low PA than in those with high PA. Additionally, the elderly with low PA showed significantly reduced HGS compared to that of the elderly with high PA (-1.00 (-2.27, 0.55) kg vs. 0.10 (-1.40, 1.10) kg, P < 0.05). However, changes in HGS in younger patients were not significant (-0.02 (1.83, 1.47) kg vs. 0.25 (-2.45, 2.05) kg, P = 0.96). Logistic regression analyses identified PA as the independent factor for prevention of decrease in HGS (odds ratio: 1.91, 95% confidence interval: 1.00 - 3.62, P = 0.049). CONCLUSIONS: Young patients with low PA were characterized by a long sedentary time; however, there was no loss of HGS. In contrast, elderly patients with CLD and low PA had significantly reduced HGS compared to that in elderly patients with CLD and high PA. |
format | Online Article Text |
id | pubmed-6785279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-67852792019-10-21 Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease Ohashi, Kazuki Ishikawa, Toru Hoshii, Asami Hokari, Tamaki Suzuki, Mitsuyuki Mitobe, Yuta Yamada, Etsuko Abeywickrama, Hansani Madushika Kikuchi, Yuko Noguchi, Hirohito Hirosawa, Hiroshi Koyama, Yu J Clin Med Res Original Article BACKGROUND: Sarcopenia is a prognostic factor for patients with liver cirrhosis and hepatocellular carcinoma, and it affects the onset of hepatic encephalopathy. Therefore, the prevention of sarcopenia contributes to the improvement of the prognosis of patients with chronic liver disease (CLD). We focused on changes of hand grip strength (HGS), one of the indicators of sarcopenia. However, there are little data investigating the impact of physical activity (PA) on HGS in patients with CLD. This study aimed to clarify whether PA contributes to the prevention of muscle weakness in patients with CLD. METHODS: This was a prospective observational study. We examined the effect of PA on changes in HGS from the baseline to the endpoint in each group. Metabolic equivalents-hour/week (METs-h/w) was used to evaluate PA. In total, 183 outpatients with CLD were analyzed. We divided participants into four groups (low PA in younger patients (n = 20), high PA in younger patients (n = 33), low PA in elderly patients (n = 47), and high PA in elderly patients (n = 83)). RESULTS: Fifty-eight percent of patients were men, and the median (interquartile range) age was 69.0 (63.0, 75.0) years. The most common etiology of liver disease was hepatitis C (38%). The frequency of living alone and low exercise habit was significantly high, and sarcopenia was more obvious in elderly patients with low PA than in those with high PA. Additionally, the elderly with low PA showed significantly reduced HGS compared to that of the elderly with high PA (-1.00 (-2.27, 0.55) kg vs. 0.10 (-1.40, 1.10) kg, P < 0.05). However, changes in HGS in younger patients were not significant (-0.02 (1.83, 1.47) kg vs. 0.25 (-2.45, 2.05) kg, P = 0.96). Logistic regression analyses identified PA as the independent factor for prevention of decrease in HGS (odds ratio: 1.91, 95% confidence interval: 1.00 - 3.62, P = 0.049). CONCLUSIONS: Young patients with low PA were characterized by a long sedentary time; however, there was no loss of HGS. In contrast, elderly patients with CLD and low PA had significantly reduced HGS compared to that in elderly patients with CLD and high PA. Elmer Press 2019-10 2019-10-04 /pmc/articles/PMC6785279/ /pubmed/31636786 http://dx.doi.org/10.14740/jocmr3978 Text en Copyright 2019, Ohashi et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ohashi, Kazuki Ishikawa, Toru Hoshii, Asami Hokari, Tamaki Suzuki, Mitsuyuki Mitobe, Yuta Yamada, Etsuko Abeywickrama, Hansani Madushika Kikuchi, Yuko Noguchi, Hirohito Hirosawa, Hiroshi Koyama, Yu Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease |
title | Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease |
title_full | Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease |
title_fullStr | Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease |
title_full_unstemmed | Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease |
title_short | Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease |
title_sort | efficacy of physical activity in prevention of muscle weakness in patients with chronic liver disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785279/ https://www.ncbi.nlm.nih.gov/pubmed/31636786 http://dx.doi.org/10.14740/jocmr3978 |
work_keys_str_mv | AT ohashikazuki efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT ishikawatoru efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT hoshiiasami efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT hokaritamaki efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT suzukimitsuyuki efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT mitobeyuta efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT yamadaetsuko efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT abeywickramahansanimadushika efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT kikuchiyuko efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT noguchihirohito efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT hirosawahiroshi efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease AT koyamayu efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease |